We are pleased to inform you that the European Board of Internal Medicine, EBIM a joint collaboration between EFIM and the UEMS Section of Internal Medicine launched the Educational Platform online.
Access here the EBIM website: https://www.ebim-online.org/ .
EBIM is committed to advancing postgraduate education in internal medicine in Europe through guidance on the standardisation of training and practice of internal medicine within Europe for the benefit of patient care. 

We are pleased to invite you to register to the upcoming Webinar on Overdiagnosis and Low Value Healthcare organised by the EFIM Choosing Wisely.
To connect to the webinar on 12 October please click on the Zoom link below:
https://zoom.us/j/4776343293
To follow the Special presentation (Choosing Wisely International Roundtable) by Prof. Don Berwick on 13 October please make sure you register to the link below:

The medical profession is facing increasing pressure to adapt its patient care to optimize the economic benefit for hospitals and practices.

The Young Internists section of EFIM hosted the  webinar “Headache: Clinical approach and management of patients with headaches within Acute Internal and Emergency Medicine on Monday, 14 September f. The webinar ws presented by Prof. Ben Lovel from UK, from UK, an Associate Professor of Medical Education and a consultant in Acute Internal Medicine at University College Hospital, where he is also the postgraduate lead for Acute Medicine.
View the webinar via EFIM You Tube channel on the link below:
https://youtu.be/hnPyxADPkyk

Dear EFIM Members,

We are pleased to  inform you that the next General Assembly will be organised virtually via the Zoom platform on Friday, 25 September 2020.
Please register on the link below to attend the next General Assembly.

https://us02web.zoom.us/webinar/register/WN_QDA1oMBFTLi4KKOaviQNHQ

We are looking forward to talking to you in September!

We are pleased to inform you that EFIM IMAGINE Working Group published their paper  "IMAGINE the future - a voice of young internists" in JAMA under the title "Sex, Gender, and Precision Medicine". Article can be accessed via JAMA website.

Tocilizumab is a recombinant humanized monoclonal IL-6 receptor antibody indicated for the treatment of severe rheumatoid arthritis and other inflammatory disorders.Following clinical observation from China, a series of Italian studies have been carried out to evaluate the off-label use of tocilizumab in COVID-19 patients.
The European Journal of Internal Medicine (EJIM) has recently accepted for publication three articles on the off-label use of tocilizumab in patients with severe COVID-19.

Visit the Information Center available through our publisher Elsevier, to find the most relevant research on the Novel Coronavirus (COVID-19), freely available here.

FDIME Announces Research Grants in 2020

The Foundation for the Development of Internal Medicine in Europe (FDIME) is offering Research Grants to Young Internists (up to age 38 yrs) to study in:
Research projects including all fields of General Internal Medicine, particularly polymorbidity and other common Internal Medicine conditions.

For details check the FDIME Research Grants webpage at www.fdime.org
OR

Download the Internal Medicine Grant Announcement and Application Form

For further information: